Laboratory products
Flu Tests Detect New Virus Variants
Nov 28 2022
The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.
"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explained Dr Andreas Simons, Head of Product Management at R-Biopharm. "Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."
This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.
More information online
Digital Edition
ILM 50.3 April 2025
May 2025
Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...
View all digital editions
Events
May 18 2025 Brussels, Belgium
InformEx Zone at CPhl North America
May 20 2025 Philadelphia, PA, USA
May 21 2025 Birmingham, UK
May 27 2025 Basel, Switzerland
Jun 01 2025 Baltimore, MD, USA